Key points are not available for this paper at this time.
Elevated lipoprotein(a) (Lpa) is a putative causal risk factor for atherosclerotic cardiovascular disease (ASCVD). There are conflicting data as to whether Lp(a) may increase cardiovascular risk only in the presence of concomitant inflammation.
Small et al. (Wed,) studied this question.